{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:13:48Z","timestamp":1790284428556,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sohag University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There has been growing attention toward the predictive value of the coagulation parameters abnormalities in COVID-19. The aim of the study was to investigate\u00a0the role of coagulation parameters namely Prothrombin concentration (PC), activated Partial thromboplastin Time (aPTT), D-Dimer (DD), Anti Thrombin III (ATIII) and fibrinogen (Fg) together with hematological, and biochemical parameters in predicting the severity of COVID-19 patients and estimating their\u00a0relation to clinical outcomes in hospitalized and severe COVID-19 Patients. In a prospective study, a total of 267 newly diagnosed COVID-19 patients were enrolled. They were divided into two groups; hospitalized group which included 144 patients and non-hospitalized group that included 123 patients. According to severity, the patients were divided into severe group which included 71 patients and non-severe group that included 196 patients who were admitted to ward or not hospitalized. Clinical evaluation, measurement of coagulation parameters, biochemical indices, outcome and survival data were recorded. Hospitalized and severe patients were older and commonly presented with dyspnea (P\u2009\u2264\u20090.001). Differences in coagulation parameters were highly significant in hospitalized and severe groups in almost all parameters, same for inflammatory markers. D-dimer, AT-III and LDH showed excellent independently prediction of severity risk. With a cut-off of\u2009&gt;\u20092.0\u00a0ng\/L, the sensitivity and specificity of D dimer in predicting severity were 76% and 93%, respectively. Patients with coagulation abnormalities showed worse survival than those without (p\u2009=\u20090.002). Early assessment and dynamic monitoring of coagulation parameters may be a benchmark in the prediction of COVID-19 severity and death.<\/jats:p>","DOI":"10.1038\/s41598-022-16915-8","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T06:04:30Z","timestamp":1659333870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Coagulation parameters abnormalities and their\u00a0relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0607-5508","authenticated-orcid":false,"given":"Hend M.","family":"Esmaeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud I.","family":"Elbadry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa R.","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhaisam M.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"16915_CR1","first-page":"1268","volume":"1","author":"AS Fauci","year":"2020","unstructured":"Fauci, A. S., Lane, H. C. & Redfield, R. R. Covid-19\u2014navigating the uncharted. Mass Med. Soc. 1, 1268\u20131269 (2020).","journal-title":"Mass Med. Soc."},{"issue":"4","key":"16915_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18(4), 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"16915_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos, E. et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 95(7), 834\u2013847 (2020).","journal-title":"Am. J. Hematol."},{"key":"16915_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3889\/oamjms.2021.6026","volume":"9","author":"J Arifputra","year":"2021","unstructured":"Arifputra, J., Haroen, H., Rotty, L. W. A., Lasut, P. F. C. & Hendratta, C. Coagulopathy of coronavirus disease 2019: A case series. Open Access Macedonian J. Med. Sci. 9, 301\u2013307 (2021).","journal-title":"Open Access Macedonian J. Med. Sci."},{"key":"16915_CR5","unstructured":"Organization WH. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization, 2020."},{"key":"16915_CR6","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Bethesda (MD): National Institutes of Health (US) (2021)."},{"issue":"1","key":"16915_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5935\/0103-507X.20190010","volume":"31","author":"EC Martins","year":"2019","unstructured":"Martins, E. C. et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: A case-control study. Revista Brasileira de terapia intensiva. 31(1), 64\u201370 (2019).","journal-title":"Revista Brasileira de terapia intensiva."},{"issue":"7","key":"16915_CR8","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 18(7), 1738\u20131742 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"16915_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.5858\/arpa.2020-0324-SA","volume":"144","author":"Y Fei","year":"2020","unstructured":"Fei, Y., Tang, N., Liu, H. & Cao, W. Coagulation DysfunctionA Hallmark in COVID-19. Arch. Pathol. Lab. Med. 144(10), 1223\u20131229 (2020).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"16915_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjh.17986","volume":"196","author":"MI Elbadry","year":"2021","unstructured":"Elbadry, M. I. et al. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia. Br. J. Haematol. 196, 902 (2021).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"16915_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","volume":"100","author":"H-c Luo","year":"2021","unstructured":"Luo, H.-c, You, C.-y, Lu, S.-w & Fu, Y.-q. Characteristics of coagulation alteration in patients with COVID-19. Ann. Hematol. 100(1), 45\u201352 (2021).","journal-title":"Ann. Hematol."},{"key":"16915_CR12","doi-asserted-by":"crossref","unstructured":"Long, H., Nie, L., Xiang, X., Li, H., Zhang, X., & Fu, X., et al. D-dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. BioMed Res. Int. (2020).","DOI":"10.1155\/2020\/6159720"},{"issue":"4","key":"16915_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11239-020-02174-9","volume":"50","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. J. Thromb. Thrombolysis 50(4), 825\u2013832 (2020).","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"16915_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China. JAMA Int. Med. 180(7), 934\u2013943 (2020).","journal-title":"China. JAMA Int. Med."},{"issue":"10229","key":"16915_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 395(10229), 1054\u20131062 (2020).","journal-title":"The lancet."},{"issue":"3","key":"16915_CR16","first-page":"3696","volume":"14","author":"BD Rathod","year":"2022","unstructured":"Rathod, B. D., Amle, D., Khot, R. S., Prathipati, K. K. & Joshi, P. P. Neutrophil-to-Lymphocyte ratio as a predictor of disease severity and mortality in coronavirus disease 2019: Prospective study From Central India. Cureus. 14(3), 3696 (2022).","journal-title":"Cureus."},{"key":"16915_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.thromres.2020.05.006","volume":"192","author":"J Fu","year":"2020","unstructured":"Fu, J. et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb. Res. 192, 3\u20138 (2020).","journal-title":"Thromb. Res."},{"key":"16915_CR18","doi-asserted-by":"crossref","unstructured":"Harzallah, I., Debliquis, A., & Dr\u00e9nou, B. Lupus anticoagulant is frequent in patients with Covid-19: Response to reply. J Thromb Haemostasis (2020).","DOI":"10.1111\/jth.14980"},{"key":"16915_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104362","volume":"127","author":"D Giannis","year":"2020","unstructured":"Giannis, D., Ziogas, I. A. & Gianni, P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J. Clin. Virol. 127, 104362 (2020).","journal-title":"J. Clin. Virol."},{"issue":"6","key":"16915_CR20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18(6), 1421\u20131424 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"16915_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268820001442","volume":"148","author":"Q Liu","year":"2020","unstructured":"Liu, Q., Song, N., Zheng, Z., Li, J. & Li, S. Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: A retrospective study. Epidemiol. Infect. 148, 1 (2020).","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"16915_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-020-00172-4","volume":"9","author":"C Bao","year":"2020","unstructured":"Bao, C. et al. SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients. Exp. Hematol. Oncol. 9(1), 1\u20138 (2020).","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"16915_CR23","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","volume":"7","author":"D Liao","year":"2020","unstructured":"Liao, D. et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: A retrospective cohort study. Lancet Haematol. 7(9), e671\u2013e678 (2020).","journal-title":"Lancet Haematol."},{"issue":"10","key":"16915_CR24","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/jmv.25884","volume":"92","author":"J Zhu","year":"2020","unstructured":"Zhu, J. et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J. Med. Virol. 92(10), 1902\u20131914 (2020).","journal-title":"J. Med. Virol."},{"issue":"6","key":"16915_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J. Thromb. Haemost. 18(6), 1324\u20131329 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"16915_CR26","doi-asserted-by":"crossref","unstructured":"Zou, Y., Guo, H., Zhang, Y., Zhang, Z., Liu, Y., Wang, J., et al. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. Biosci. Trends. (2020).","DOI":"10.5582\/bst.2020.03086"},{"issue":"1","key":"16915_CR27","first-page":"15","volume":"38","author":"\u0130 Anakl\u0131","year":"2021","unstructured":"Anakl\u0131, \u0130 et al. Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: A retrospective study. Turk. J. Hematol. 38(1), 15 (2021).","journal-title":"Turk. J. Hematol."},{"key":"16915_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bjh.16927","volume":"190","author":"DJ Arachchillage","year":"2020","unstructured":"Arachchillage, D. J. et al. Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19. Br. J. Haematol. 190, 5 (2020).","journal-title":"Br. J. Haematol."},{"key":"16915_CR29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/bjh.17575","volume":"194","author":"AJ Gardner","year":"2021","unstructured":"Gardner, A. J. et al. Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: A case series. Br. J. Haematol. 194, 1007 (2021).","journal-title":"Br. J. Haematol."},{"issue":"4","key":"16915_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11239-020-02174-9","volume":"50","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. J. Thromb. 50(4), 825\u2013832 (2020).","journal-title":"J. Thromb."},{"issue":"6","key":"16915_CR31","first-page":"580","volume":"11","author":"M Pujani","year":"2021","unstructured":"Pujani, M. et al. An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook. Am. J. Blood Res. 11(6), 580\u2013591 (2021).","journal-title":"Am. J. Blood Res."},{"issue":"11","key":"16915_CR32","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/jcm9113482","volume":"9","author":"M Quintana-D\u00edaz","year":"2020","unstructured":"Quintana-D\u00edaz, M. et al. Coagulation parameters: An efficient measure for predicting the prognosis and clinical management of patients with COVID-19. J. Clin. Med. 9(11), 3482 (2020).","journal-title":"J. Clin. Med."},{"issue":"1","key":"16915_CR33","first-page":"529","volume":"26","author":"A Khalid","year":"2021","unstructured":"Khalid, A. et al. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: A retrospective comparative analysis. Hematology (Amsterdam, Netherlands). 26(1), 529\u2013542 (2021).","journal-title":"Hematology (Amsterdam, Netherlands)."},{"issue":"10223","key":"16915_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. The lancet. 395(10223), 497\u2013506 (2020).","journal-title":"China. The lancet."},{"issue":"06","key":"16915_CR35","first-page":"1","volume":"5","author":"PK Das","year":"2021","unstructured":"Das, P. K., Upadhyay, A. K., Purohit, G. K., Pattanaik, S. & Palo, S. Hematological parameters as a prognostic biomarker in COVID-19 patients. Cytokines 5(06), 1 (2021).","journal-title":"Cytokines"},{"issue":"10226","key":"16915_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","volume":"395","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 395(10226), 809\u2013815 (2020).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16915-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:09:31Z","timestamp":1669334971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16915-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13155"}}